FindTrial
Sign In

Effect of Neuromodulation and Virtual Game on Cardiac Variation in Women with Fibromyalgia – a clinical trial

Effect of combined transcranial direct current stimulation therapy and virtual reality on cardiac autonomic modulation in women with fibromyalgia - a double blind randomized clinical trial with crossover

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2nt4byr
Enrollment
Unknown
Registered
2024-05-23
Start date
2019-12-18
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Interventions

This study presents a randomized, controlled, crossover clinical trial with two arms, employing a double-blind design, it investigates a physical activity protocol utilizing virtual reality in conjunc
E02.331.750

Sponsors

Universidade Federal de São Paulo - UNIFESP/EPM
Lead Sponsor
Universidade Federal de São Paulo - UNIFESP/EPM
Collaborator

Eligibility

Sex/Gender
Female
Age
30 Years to 50 Years

Inclusion criteria

Inclusion criteria: As inclusion criteria, was considered: women diagnosed with FM, aged between 30 and 50 years, who did not use medications that could interfere with the variables studied, such as cardiac beta blockers, and who signed the free and informed consent form.

Exclusion criteria

Exclusion criteria: As exclusion criteria: non-understanding of the task, assessed through the participant's ability to perform the task correctly after performing three attempts with explanation and demonstration by the evaluator.

Design outcomes

Primary

MeasureTime frame
It is expected from the interventions using transcranial stimulation and virtual reality will contribute to cardiac autonomic modulation in individuals with fibromyalgia—

Secondary

MeasureTime frame
No secondary outcomes are expected—

Countries

Brazil

Contacts

Public ContactTalita da Silva

Universidade Federal de São Paulo - UNIFESP/EPM

talita.dias@unifesp.br+55-11-99859-0188

Outcome results

None listed

Source: REBEC (via WHO ICTRP)